Also, due to the elevated levels of plasma IL-18, IL-12, and IL-15 in CLL patients (Additional file 1: Fig. S5u–w), we assessed the potential effects of these cytokines on CD26 expression. This evidence concerns the gene IL18 and B-cell chronic lymphocytic leukemia.